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ABSTRACT 
Keywords: OPA1, mitochondrial dynamics, mitochondrial fusion, dynamin, GTP hydrolyzing enzyme, 
membrane fusion 
OPA1, a large GTPase of the dynamin superfamily, mediates fusion of the mitochondrial inner 
membranes, regulates cristae morphology, and maintains respiratory chain function. Inner-membrane-
anchored long forms of OPA1 (l-OPA1) are proteolytically processed by the OMA1 or YME1L 
proteases, acting at cleavage sites S1 and S2 respectively, to produce short forms (s-OPA1). In both 
mouse and human, half of the mRNA splice forms of Opa1 are constitutively processed to yield 
exclusively s-OPA1. However, the function of s-OPA1 in mitochondrial fusion has been debated, because 
in some stress conditions, s-OPA1 is dispensable for fusion. By constructing cells in which the Opa1 
locus no longer produces transcripts with S2 cleavage sites, we generated a simplified system to identify 
the new YME1L-dependent site S3 that mediates constitutive and complete cleavage of OPA1. We show 
that mitochondrial morphology is highly sensitive to the ratio of l-OPA1 to s-OPA1, indicating that s-
OPA1 regulates mitochondrial fusion. 
  
 Novel s-OPA1 regulates mitochondrial fusion 
 3 
INTRODUCTION 
By controlling mitochondrial form and function, the dynamics processes of mitochondrial fusion and 
fission regulate cellular physiology, including responses to metabolic demands and cellular stress (Chan, 
2019). As double-membrane organelles, mitochondria fuse by a two-step process coordinated by a set of 
dynamin superfamily GTPases. In mammalian cells, mitochondrial outer membrane fusion mediated by 
the mitofusins MFN1 and MFN2 is followed by inner membrane fusion mediated by OPA1 (Chan, 2019). 
Each of these fusion molecules is essential for embryonic development in mouse (Chen et al., 2003; Alavi 
et al., 2007). In humans, heterozygous mutations in MFN2 and OPA1 cause the neurodegenerative 
diseases Charcot-Marie-Tooth Disease 2A and Autosomal Dominant Optic Atrophy, respectively 
(Alexander et al., 2000; Delettre et al., 2000; Chan, 2019). 
 
Due to alternative splicing and post-translational processing, the OPA1 locus gives rise to a complicated 
set of protein isoforms. In humans, OPA1 encodes for 8 mRNA splice forms that are generated by 
alternative splicing of exons 4, 4b, and 5b (Fig. S1A). In both human and mouse, the mRNA splice forms 
are expressed in a tissue-specific manner, although the purpose of this differential expression is unknown 
(Delettre et al., 2001; Akepati et al., 2008). The encoded OPA1 polypeptides are directed into 
mitochondria due to an N-terminal mitochondrial targeting sequence (MTS) that is cleaved by the 
mitochondrial processing peptidase (MPP) soon after entry of this region into the matrix. Lateral exiting 
of the polypeptide from the TIM (translocase of the inner membrane) pore results in a “long” form of 
OPA1 (l-OPA1) that is anchored in the mitochondrial inner membrane by an N-terminal transmembrane 
segment. A fraction of l-OPA1 is proteolytically cleaved beyond the transmembrane segment by either 
OMA1 or YME1L, inner membrane-anchored proteases, to produce slightly different, non-membrane-
anchored, “short” forms (s-OPA1). OMA1 cleaves at the S1 site encoded by exon 5 (Ehses et al., 2009; 
Head et al., 2009), and YME1L cleaves at the S2 site encoded by the alternative exon 5b (Griparic et al., 
2007; Song et al., 2007). For isoforms 1, 2, 4, and 7, the moderate action of these proteases typically 
results in roughly comparable levels of long versus short OPA1. In contrast, the polypeptides encoded by 
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the other 4 mRNA splice forms (3, 5, 6, and 8), which all contain exon 4b, are such avid substrates for 
proteolytic processing that they generate only short forms (Griparic et al., 2007; Song et al., 2007) (Fig. 
S1A). Although little detail is available, it has been suggested that exon 4b may encode a protease 
cleavage site (Olichon et al., 2007; Head et al., 2009; Lee et al., 2017a). Under normal conditions, a 
balanced combination of long and short forms is required to maintain high levels of  mitochondrial fusion 
(Song et al., 2007). Proteolytic processing of the OPA1 ortholog Mgm1p is also necessary for normal 
levels of mitochondrial fusion in yeast cell (DeVay et al., 2009). In contrast, either s-OPA1 or l-OPA1 is 
sufficient for the non-fusion functions of OPA1, such as maintenance of mtDNA, cristae structure, and 
respiratory chain assembly (Del Dotto et al., 2017; Lee et al., 2017b). 
 
These observations raise several important issues. How do long and short forms of OPA1 contribute to 
mitochondrial inner membrane fusion? In particular, what is the purpose of the short forms of OPA1, 
given that 4 of 8 mRNA splice isoforms give rise to exclusively short forms? There are currently two 
general models explaining how long and short OPA1 isoforms regulate inner membrane fusion activity. 
The first model is that a mixture of long and short forms is critical for fusion (Song et al., 2007; Mishra et 
al., 2014). This model is based on cell culture observations that expression of l-OPA1 or s-OPA1 alone 
results in very low mitochondrial fusion activity and that robust levels of fusion require a combination of 
both long and short forms (Song et al., 2007). Furthermore, in an in vitro fusion assay, mitochondria 
containing l-OPA1 do not fuse until partial proteolytic cleavage is triggered (Mishra et al., 2014). The 
second model is that l-OPA1 and s-OPA have distinct activities, with l-OPA1 being the only fusogenic 
form. This model is based on the observation that cells lacking OMA1 and YME1L, which produce only 
long forms of OPA1, nevertheless show tubular mitochondria and mitochondrial fusion activity (Anand et 
al., 2014). In addition, under a stress condition termed stress-induced mitochondrial hyperfusion, l-OPA1 
is sufficient for fusion activity (Tondera et al., 2009). These observations indicate that under specific 
cellular conditions, l-OPA1 alone can have substantial fusion activity, even though this does not appear to 
be the case under basal conditions. S-OPA1 has instead been suggested to have fission activity, based on 
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the observation that overexpression of s-OPA1 leads to mitochondrial fragmentation (Anand et al., 2014). 
Recent reconstitution of OPA1 fusion activity in vitro (Ban et al., 2017) has not distinguished between 
these two models, because both l-OPA1 and s-OPA1 show liposome fusion activity (Ban et al., 2018). 
However, consistent with the first model, s-OPA1 seems to work synergistically with l-OPA1 to increase 
in vitro fusion activity (Ban et al., 2017). Observation of single fusion events in another in vitro assay 
also supports the view that fusion efficiency is increased when a stoichiometric amount of s-OPA1 is 
added to l-OPA1 (Ge et al., 2020). 
To understand the role of the short forms of OPA1, we used CRISPR-Cas9 gene editing to 
generate cells and mice lacking OPA1 isoforms containing the YME1L-dependent S2 site encoded by 
exon 5b. This genetic change eliminated all OPA1 isoforms containing this exon, and we anticipated that 
the role of YME1L in regulating OPA1 function would be abrogated due to the elimination of the 
YME1L cleavage site. Surprisingly, however, OPA1 processing was still regulated by YME1L due to a 
novel cleavage site, that we term S3, encoded by the alternative exon 4b. Notably, isoform 5 contains 
exon 4b and is constitutively cleaved at S3, and therefore this mRNA isoform contributes only s-OPA1 to 
the OPA1 repertoire. In specific cellular contexts, we show that depletion of S3-generated s-OPA1 causes 
mitochondrial fragmentation, and conversely, that increased expression of S3-generated s-OPA1 induces 
mitochondrial elongation. These results demonstrate that s-OPA1 works with l-OPA1 to tune the level of 
mitochondrial fusion. 
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RESULTS 
OMA1 and YME1L differentially modulate OPA1 fusion activity 
Whereas human OPA1 has 8 different mRNA splice variants (Fig. S1A), mouse tissues express 
only four—isoforms 1, 5, 7 and 8 (Akepati et al., 2008) (Fig. 1A). Isoforms 1 and 7 each produce a 
mixture of l-OPA1 and one or two versions of s-OPA1, respectively. The short isoforms are produced by 
proteolytic cleavage of the long isoform by the mitochondrial inner membrane proteases OMA1 (at the S1 
site) and YME1L (at the S2 site). In contrast, proteolytic processing of isoforms 5 and 8 goes to 
completion and results in only short isoforms (Song et al., 2007). 
In mouse embryonic fibroblasts (MEFs), this group of 4 mRNA isoforms gives rise to five 
protein bands when cell lysates are resolved on SDS-PAGE (labeled a-e in Fig. 1A, B). Bands a and b are 
the long forms arising from isoform 7 and isoform 1, respectively (Fig. 1A). Bands c and d are S1- and 
S2-cleavage products of isoform 7 generated by OMA1 and YME1L, respectively. Band e is the short, 
S1-cleaved form of isoform 1. Isoforms 5 and 8 generate only short isoforms that would be expected to 
contribute to bands c-e (Song et al., 2007). The same set of OPA1 bands has been observed in other 
studies, although the relative intensities can vary, perhaps due to differences in culture conditions (Anand 
et al., 2014).  
The dependencies of bands c-e on the OMA1 or YME1L proteases were confirmed by the OPA1 
band pattern in lysates from Oma1-null or Yme1L-null cells (Fig. 1B). The OPA1 band patterns observed 
in the protease mutant cells are tabulated in Fig. S1B. The identities of the Oma1-null and Yme1L-null 
cells were confirmed by Western blotting against the relevant proteases (Fig. S1C). Notably, there is a 
longer band emerging in both the Yme1l-null and Yme1l/Oma1-null cells, likely due to the disruption of 
YME1L-dependent short isoform formation (i.e., isoform 8). 
To understand the role of these proteases in regulating OPA1 fusogenic function, we examined 
Oma1/Yme1l double knockout MEFs, which contain only long forms of OPA1 (Anand et al., 2014). In 
standard high glucose culture medium, these cells show increased mitochondrial fragmentation compared 
to wildtype (WT) cells (Fig. 1C, D). Many Oma1/Yme1l mutant cells nevertheless show short tubular 
 Novel s-OPA1 regulates mitochondrial fusion 
 7 
mitochondria (Fig. 1D), so the degree of mitochondrial fragmentation is substantially less severe than in 
Mfn1/Mfn2-null or Opa1-null cells (Chen et al., 2005, 2007). Oma1-null MEFs show normal 
mitochondrial morphology profiles, and Yme1l-null MEFs show highly fragmented mitochondria (Fig. 
1D). The overall trends—that mitochondria in Oma1/Yme1l mutant cells are more fragmented than in WT 
cells, but less than in Yme1l mutant cells—are consistent with a previous study (Anand et al., 2014). 
OPA1 band patterns are similar under the different media conditions (Fig. S1D). 
We tested how these mutant cells respond to culture conditions that increase the level of 
mitochondrial fusion. Cultured MEFs increase mitochondrial fusion activity and show mitochondrial 
elongation when cultured in medium that induces oxidative phosphorylation (OXPHOS). This response 
has been shown to depend on YME1L activity (Mishra et al., 2014). Consistent with this idea, we found 
mitochondrial elongation caused by OXPHOS-inducing medium to be abrogated in Yme1l-null and 
Oma1/Yme1l-null MEFs (Fig. 1C, D). As measured in the photo-activatable (PA)-GFP fusion assay, 
mitochondrial fusion under basal conditions was substantially reduced in Oma1/Yme1-null MEFs 
compared to WT cells and did not increase in response to OXPHOS-inducing medium (Fig. 1E). In 
contrast, cells of all genotypes tested in this study show robust mitochondrial elongation in response to 
cycloheximide (CHX) treatment, which causes stress-induced mitochondrial hyperfusion (Tondera et al., 
2009)  (Fig. 1C, D, E). Hyperfusion is induced rapidly after the addition of CHX (Fig. 1E). CHX 
treatment enhanced PA-GFP signal dilution in both WT and Oma1/Yme1l-null cells. WT cells showed a 
substantially greater fusion rate than the latter, indicating the reduced fusion capability in Oma1/Yme1l-
null cells even in the presence of a strong fusion stimulus. Taken together, our observations agree with the 
previous finding that Oma1/Yme1l-null cells, containing only l-OPA1, retain mitochondrial fusion activity 
(Anand et al., 2014). However, the level of fusion activity is substantially lower compared to WT cells. 
The OMA1 and YME1L proteases differentially regulate OPA1 function. Stress-induced hyperfusion 
does not depend on either protease, consistent with the report that l-OPA1 is sufficient in mediating 
fusion under this stress condition (Tondera et al., 2009). In contrast, OXPHOS-induced mitochondrial 
elongation is dependent on YME1L activity, as noted previously (Mishra et al., 2014).  
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The Opa1 S2 site is necessary for mediating OXPHOS-induced fusion in vivo 
To clarify the functions of YME1L-dependent cleavage of OPA1, we used CRISPR-Cas9-
mediated gene targeting in MEFs to generate mutations in the Opa1 genomic locus at exon 5b, which 
encodes the S2 cleavage site (Fig. 2A, B). We hoped to generate deletions in exon 5b that would disrupt 
the Opa1 reading frame, resulting in a downstream premature stop codon that would prevent the 
formation of functional OPA1 isoforms containing S2. In this scenario, the mutant cells would be 
expected to have only long isoform 1 (band b) and the corresponding S1 cleavage product (band e). Bands 
a, c, and d would be missing, because those arise from exon 5b-containing transcripts (Fig. 2B). 
After transient expression of Cas9 and sgRNA against the exon 5b target in MEFs, we identified 
multiple colonies that lacked bands a, c, and d (Fig. 2C). To ensure against clone-specific effects, we used 
three or more ∆exon 5b clones in all our experiments, and results from two different clones are shown in 
the figures. DNA sequencing showed that clone 1 has a homozygous two-nucleotide deletion, and clone 2 
has two longer deletions that each cause frameshifting (Fig. 2A).  
The ∆exon 5b cells showed normal mitochondrial profiles when grown in regular glucose-
containing medium. In addition, they showed a normal stress-induced hyperfusion response, dramatically 
elongating mitochondria upon CHX stimulation (Fig. 2D and Fig. S2A). In OXPHOS-inducing medium, 
however, the mutant cells did not show any elongation of mitochondria compared to growth in control 
medium, indicating that S2-cleavage of Opa1 is required for OXPHOS-induced hyperfusion. Although 
OXPHOS-inducing medium does not promote mitochondrial elongation in ∆exon 5b cells, we did not 
detect physiological consequences. OXPHOS-inducing medium caused upregulation of oxygen 
consumption in these cells (Fig. S2B), indicating that the increase in respiratory function is not dependent 
on mitochondrial elongation. Moreover, both WT cells and ∆exon 5b cells showed similar cell growth 
after switching to OXPHOS-inducing medium (Fig. S2C). In addition to MEFs, we generated two ∆exon 
5b mouse lines. Western analysis of mutant tissues showed abrogation of Opa1 exon 5b-containing 
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protein bands (Fig. S2D). Despite this biochemical change in OPA1 isoforms, the mutant mice showed no 
obvious physiological dysfunction and gained weight normally (Fig. S2E) for at least one year of age.  
 
Detection of a new OPA1 cleavage site in WT and ∆exon 5b cells 
In the course of this study, we switched to a higher resolution gel system to study these OPA1 protein 
isoforms. With this new system, what was previously designated as band d in WT cells could be resolved 
into doublet bands, which we designate as d and d’ (Fig. 3A). Upon reanalysis, we realized that ∆exon 5b 
cells produce two short Opa1 bands, d’ and e. With deletion of the YME1L-dependent S2 site, ∆exon 5b 
cells would be expected to show only OMA1-mediated processing of OPA1. In ∆exon 5b/Oma1-null 
cells, band e is missing but d’ band remains, indicating that it is OMA1-independent (Fig. 3A). 
Because YME1L is the other known intermembrane protease involved in OPA1 posttranslational 
processing, we used shRNA to test whether it is essential for the production of band d’. The knockdown 
efficiencies of the Yme1l and Oma1 shRNAs were confirmed by Western blotting (Fig. S3A, B). In WT 
cells, knockdown of YME1L caused the disappearance of band d and d’, whereas knockdown of OMA1 
caused the disappearance of bands c and e (Fig. 3B). The dependence of d’ on YME1L but not OMA1 
was further confirmed in both ∆exon 5b/Oma1-null cells and ∆exon 5b cells (Fig. 3B).  
To identify the source of the new short OPA1 band d’, we used PCR analysis of cDNA from 
∆exon 5b cells to identify the major remaining Opa1 mRNA transcripts. Using primers flanking the 
alternative splicing exons 4, 4b and 5b to distinguish individual mRNA transcripts (Fig. S3C), we found 
that the mutant cells expressed mRNA splice variants 1 and 5 (confirmed both by PCR analysis and 
sequencing), with isoform 1 being slightly more abundant (Fig. 3C, D). It is not surprising that isoforms 7 
and 8 are missing, because they contain exon 5b. Isoform 5 instead contains the alternative exon 4b (Fig 
3D), and like other exon 4b-containing isoforms, was previously shown to be constitutively cleaved into a 
short isoform (Song et al., 2007). The constitutive cleavage of isoform 5 was assumed to occur at the S1 
site, the only known cleavage site in this isoform (Song et al., 2007). However, we wondered whether this 
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assumption might be incorrect, because cleavage of isoform 5 at S1 would lead to band e, not d’. To test 
whether isoform 5 could generate band d’, we expressed isoform 5 in Opa1-null cells. Isoform 5 
generated a short isoform that was clearly distinct from e and co-migrated with the d’ bands present in 
∆exon 5b and ∆exon5b/Oma1-null cells (Fig. 3E). This observation indicates that isoform 5 is the likely 
source of band d’. Its cleavage site is N-terminal to S1, as indicated by the slightly larger size of d’ 
compared to e. 
To determine the protease responsible for cleavage of isoform 5, and further confirm that the 
YME1L-dependent band d’ indeed arises from isoform 5, we compared the behavior of C-terminal 
FLAG-tagged human isoforms 5 and 1 in mutant MEFs lacking OMA1 or YME1L. Consistent with 
previous studies showing cleavage at S1 by OMA1, isoform 1-FLAG produces a short isoform that is 
dependent on OMA1 (Fig. 3F). When YME1L is absent, more of this short isoform is produced, 
presumably due to upregulation of OMA1 activity (Wai et al., 2015). As expected, isoform 5-FLAG is 
completely processed in control MEFs. The absence of OMA1 does not affect the cleavage pattern, 
indicating that the production of isoform 5 short form is independent of OMA1 (Fig. 3F). The removal of 
Yme1l completely abrogates production of this short form and results in a lower band that co-migrates 
with the short isoform generated from isoform 1 (Fig. 3F). In addition, a small amount of the long form, 
previously absent, is formed. These results indicate that, under normal conditions, isoform 5 is processed 
to completion at a site upstream of S1, in a YME1L-dependent manner, to produce band d’. When 
YME1L is absent, cleavage is activated at the downstream S1 site. Only the long form is generated from 
isoform 5 when both OMA1 and YME1L are absent (Fig. 3F, last lane). Together, the results suggest that 
OPA1 isoform 5 is highly susceptible to protease processing, normally by YME1L. In the absence of 
YME1L, OMA1 processes isoform 5 into S1-cleaved OPA1. No additional proteases are sufficient for 
isoform 5 cleavage, as indicated by the formation of long isoform 5 when both Yme1l and Oma1 are 
absent.  
 
Identification of a leucine-rich, YME1L-dependent cleavage site in exon 4b 
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Our results so far suggest that isoform 5 contains a novel YME1L-dependent cleavage site 
upstream of S1. To pinpoint the new cleavage site (which we designate as S3), we asked if cleavage is 
dependent on exon 4b, the first exon upstream of exon 5. Knockdown of exon 4b with shRNA 
substantially reduced the intensity of band d’ in WT, ∆exon 5b, and ∆exon 5b/Oma1-null cells (Fig. 4A, 
band d’ marked with asterisks). This dependence suggests that the cleavage site likely resides in exon 4b. 
To test this idea, we analyzed the behavior of a series of isoform 5 mutants (Mut 1-9) containing various 
short deletions within exon 4b (Fig. 4B). Mutants 1, 2 and 3, containing deletions in the 5’ half of exon 
4b, show no defect in isoform 5 cleavage processing, indicating that the first half of exon 4b does not 
contain the cleavage site (Fig. 4C). Mutations 4, 5 and 6 result in small amounts of the long form, which 
normally is absent. In addition, these mutants show prominent production of band e. Mutants 7 and 8 also 
show presence of the long form and band e. In addition, these mutants show novel cleavage products 
forming a smear above band e (Fig. 4C). Mutation 9, which deleted the bridging amino acids between 
exon 4b and 5, generates band e and produces new cleavage products without generating a long form of 
isoform 5. These results suggest that S3 cleavage is sensitive to mutations in the 3’ half of exon 4b, and 
particularly to mutations (mutants 7 and 8) affecting a stretch of 5 consecutive leucines (amino acids 199-
203 in isoform 5). Interestingly, the most prominent effects of the mutations are in appearance of the long 
form and novel cleavage products, rather than in elimination of band d’.  
To determine the proteases responsible for cleavage of the mutants, we expressed the FLAG-
tagged mutants in protease mutant MEFs (Fig. 4D). In mutants 6 and 7, the smallest cleavage product 
disappeared in Oma1-null cells, indicating that it is OMA1-dependent. In mutant 7, there are larger short 
forms that are YME1-dependent.  In the absence of both OMA1 and YME1L, no cleavage was observed, 
demonstrating that these two proteases are essential for isoform 5 processing.   
To identify the cleavage site more precisely, we used tandem mass spectrometry to determine the 
N-terminal sequence of band d’, produced by overexpression of FLAG-tagged human isoform 5 in 293T 
cells. Band d’ was collected by immunoprecipitation against FLAG tag, resolved on SDS-PAGE, and 
isolated for biochemical analysis. Peptides were generated by trypsin digestion and identified by liquid 
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chromatography coupled with nanospray ionization tandem mass spectrometry (LC-MS). Of the peptides 
identified, only three peptides had nontryptic N-termini. The two predominant ones had N-termini located 
within exon 4b, beginning with the second to last leucine and last leucine of the penta-leucine stretch (Fig 
4E). The latter peptide had by far the highest intensity, suggesting that it represents the predominant S3 
cleavage product. To test this idea, we designed isoform 5 mutants (mutants 10-13) in which the last 1-3 
leucines of the penta-leucine stretch were substituted with alanine. We found that substitution of a single 
leucine (mutants 12 and 13) had little effect on band d’ production, though a small level of larger 
cleavage products could be observed (Fig. 4F). When both of the last two leucines were substituted 
(mutant 11), there was a more substantial level of aberrant cleavage, and the long isoform appeared. Both 
these effects were increased when the last three leucines were substituted (mutant 10). Taken together, the 
LC-MS and mutational analysis strongly argue that the S3 cleavage site lies within the penta-leucine 
stretch encoded by the end of exon 4b. Although the product ion spectra indicated that cleavage primarily 
occurs N-terminal to the last leucine, the mutational phenotypes suggest that cleavage can occur at other 
locations very near the penta-leucine stretch (Fig. 4C, lane 9-13). None of the mutations completely 
eliminate production of band d’, suggesting that cleavage can still occur very close to S3 when the site is 
mutated. It is also apparent that isoform 5 is highly prone to proteolytic processing--when the S3 site is 
mutated, cleavage is activated at S1 or at cryptic sites N-terminal to S3, leading to variant cleaved forms 
of isoform 5. Our analysis indicates that ∆exon5b cells retain two dominant Opa1 mRNA transcripts, 
isoforms 1 and 5.  This simplified transcript profile results in one l-OPA1 (from isoform 1) and two s-
OPA1 (isoform 1/S1 and isoform 5/S3) (Fig. 4G).  
 
The S3-cleaved short form of isoform 5 regulates mitochondrial tubulation 
In both human and mouse, half of the Opa1 splice forms contain exon 4b and are constitutively 
cleaved to yield exclusively short isoforms (Song et al., 2007). This raises the issue of why Opa1 encodes 
multiple mRNA splice forms whose only apparent purpose is to generate short isoforms. We used isoform 
5 to address this issue. Consistent with previous studies (Song et al., 2007), isoform 5 has almost no 
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mitochondrial elongation activity when expressed in Opa1-null MEFs, which have highly fragmented 
mitochondria due to the complete loss of inner membrane fusion (Fig. 5A, S5A and S4A). Isoform 5 
mutations that disrupt S3 processing, however, show substantial mitochondrial fusion activity, as 
indicated by their ability to elongate mitochondria (Fig. 5A, S5A and S4A, B). Because these mutants 
produce a variety of short forms as well as a long form, these results fit with the model that a mixture of 
long and short isoforms of OPA1 is important for mitochondrial fusion activity (Song et al., 2007). 
Alternatively, these results could be explained by proposing that it is the production of the long isoform 
that induces mitochondrial fusion activity. 
To distinguish between these two models, we further probed the physiological function of the 
short form of isoform 5. We used shRNA to knockdown exon 4b in ∆exon 5b and ∆exon 5b/Oma1-null 
cells, which have a simplified portfolio of Opa1 mRNA splice forms. As expected, knockdown of exon 
4b resulted in reduction of band d’ in both cell lines (Fig. 4A, Fig 5B). In the ∆exon 5b MEFs, exon 4b 
knockdown leads to dramatic mitochondrial fragmentation (Fig. 5C, Fig. S5B). Similarly, in ∆exon 
5b/Oma1-null cells, knockdown of exon 4b results in mitochondrial fragmentation (Fig. 5C, Fig. S5B). 
To verify that the knockdown result is not due to off-target effects, we re-expressed isoform 5 in the exon 
4b knockdowns (Fig. 5B) and observed elongation of mitochondrial morphology in both cell lines (Fig. 
5C, Fig. S5B). 
To further test this idea that a short form of OPA1 can collaborate with a long form to regulate 
mitochondrial fusion, we developed an expression system to co-express two different OPA1 splice forms 
in Opa1-null MEFs. We constructed a bicistronic expression vector to generate isoform 1 along with 
isoform 5, or isoform 1 along with control YFP.  Western blot confirmed the expected OPA1 band pattern 
in these cells (Fig. 5D). With isoform 1 expression alone, the long band b and the short band e were 
produced. With bicistronic expression of isoform 1 and isoform 5, an additional short form (d’ from 
isoform 5) was added. This dual expression recapitulated the bands observed in ∆exon 5b cells (Fig. 5D) 
and resulted in longer mitochondrial profiles. Significantly more cells contained interconnected 
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mitochondria, and fewer cells had fragmented mitochondria, compared to expression of isoform 1 alone 
(Fig. 5E, Fig. S5C). These results suggest that S3-cleaved s-OPA1 can work with l-OPA1 to promote 
mitochondrial fusion. To determine whether this synergy requires GTP hydrolysis activity in s-OPA1, we 
used the bicistronic system to express  wildtype isoform 1 with isoform 5 containing a dysfunctional 
GTPase domain (iso 5-G300E) in Opa1-null MEFs. The protein band pattern was similar in cells 
expressing Iso 1-IRES-Iso 5-G300E compared to cells expressing Iso 1-IRES-Iso 5 (Fig. S5D). The 
mutated isoform 5 was ineffective at promoting mitochondrial fusion in combination with wildtype 
isoform 1, demonstrating that GTPase activity is required in s-OPA1 to maintain fusion function (Fig. S5 
C, E).  
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DISCUSSION 
In this study, we have identified a new site, S3, that is efficiently cleaved by Yme1L to yield s-
OPA1. It remains to be determined why YME1L cleaves at S3 much more efficiently than at S2. A short 
hydrophobic sequence (FAWFP) has been found to act as a degron for YME1L (Shi et al., 2016). 
However, no similar sequences are apparent in exon 4b or the rest of OPA1. Upon recognition of 
substrates, YME1L uses ATP hydrolysis to progressively translocate them towards the proteolytic center 
(Quirós et al., 2015; Puchades et al., 2017). It is plausible that S3, or the region surrounding it, increases 
the recognition of OPA1 as a Yme1L substrate or its translocation. Future studies can address these 
issues.  
The OPA1 locus has several mechanisms that safeguard production of s-OPA1. Of the 8 OPA1 
mRNA isoforms in humans, 4 contain exon 4b (Delettre et al., 2001) and encode polypeptides that are 
fully processed to s-OPA1 (Song et al., 2007). In the mouse, only 4 mRNA isoforms are expressed 
(Akepati et al., 2008), but  similar to humans, half of them contain exon 4b and produce only s-OPA1. 
With our identification of S3, there are now three cleavage sites that result in the production of s-OPA1 
(Fig. 5F). This apparent redundancy of sites ensures production of s-OPA1 when one mechanism is 
disrupted. There is evidence that s-OPA1 is important for cell health, especially under conditions of 
oxidative stress (Lee et al., 2020). 
The redundancy of two YME1L-dependent sites (S2 and S3) likely explains why mice lacking the 
S2 site do not show obvious physiological abnormalities. In ∆exon 5b mice and cells, RNA isoforms 
retaining the S3 site are still present and produce sufficient levels of YME1L-dependent s-OPA1 to 
maintain cellular function. In addition to redundancy of S2 and S3, there appears to be crosstalk between 
sites to ensure cleavage of OPA1 precursors. With isoform 5, for example, mutation of the S3 site does 
not abrogate proteolytic processing of OPA1. Rather, it activates OMA1-dependent cleavage at S1 and 
YME1L-dependent cleavage at upstream cryptic sites, resulting in new short isoforms (Fig. 5F). 
Similarly, mutation of the S1 site activates cryptic cleavage sites (Song et al., 2007). The presence of 
these multiple mechanisms to generate s-OPA1 suggests that the processed forms likely play an important 
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functional role. It is known that s-OPA1 alone is functional for maintenance of mitochondrial DNA, 
respiratory complexes, and cristae structure (Del Dotto et al., 2017; Lee et al., 2017b), but its role in 
modulating mitochondrial fusion has been less clear. 
Our results support a model in which s-OPA1 collaborates with l-OPA1 to regulate mitochondrial 
inner membrane fusion. This principle can be readily observed in our engineered cells that have various 
altered combinations of OPA1 isoforms. In ∆exon 5b/Oma1-null cells, only one long form and one short 
form are produced. Further reduction of s-OPA1 in these cells causes dramatic mitochondrial 
fragmentation (Fig. 5C). Although the long forms by themselves can have fusion activity under certain 
contexts (mainly the stress-induced hyperfusion condition) (Tondera et al., 2009), l-OPA1 alone is 
ineffective at maintaining tubular mitochondrial morphology after exon 4b is knocked down in ∆exon 
5b/Oma1-null cells, which then produce only the long form of isoform 1 (band b). Similarly, cells 
expressing both isoform 1 and 5 show more tubular mitochondria compared to cells expressing only 
isoform 1, suggesting that additional production of s-OPA1 in this case promotes mitochondrial fusion 
(Fig. 5E). These results suggest that the ratio of l-OPA1 to s-OPA1 is an important parameter affecting 
fusion levels.  
At present, there is no evidence that the various short forms of OPA1 are functionally distinct 
with respect to their role in mitochondrial fusion, i.e., the slight differences in the length of S2-cleaved 
versus S3-cleaved s-OPA1 probably does not affect their biochemical properties. Our working model is 
that all the short forms are functionally similar. Mechanistically, the enhancement of tubular mitochondria 
by s-OPA1 requires its GTP hydrolysis activity (Fig. S5C, E), suggesting that it plays an enzymatic role 
in this process. The multiple cleavage sites allow for production of short forms under basal and stress 
conditions. 
Similar to these results, in two distinct in vitro fusion assays, l-OPA1 was sufficient to mediate 
membrane fusion, but the addition of increasing amounts of s-OPA1 to the same reaction caused higher 
levels of liposome fusion (Ban et al., 2017; Ge et al., 2020). A previous study suggested that 
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overexpression of s-OPA1 leads to mitochondrial fission, a result interpreted as supporting a role in 
fission (Anand et al., 2014). We cannot rule out a role of s-OPA1 in fission. However, it is possible that 
overexpression of s-OPA1 causes an imbalance of the l- to s-OPA1 ratio, which we have shown is critical 
for controlling mitochondrial dynamics. Likewise, it has been demonstrated in vitro that excessive s-
OPA1 in relation to l-OPA1 inhibits membrane fusion (Ge et al., 2020). 
It should be noted that the S3 cleavage site we have discovered is a mechanism for constitutive 
cleavage in OPA1 isoforms containing exon 4b, rather than for induced cleavage under special 
physiological cues or cellular stress conditions, as is the case for S1 (constitutive and CCCP-inducible). 
Unlike isoforms containing S1 and S2, which are partially cleaved to generate a cohort of long and short 
forms, isoforms containing S3 are fully processed under basal conditions to produce solely s-OPA1. The 
physiological importance of this constitutive cleavage is indicated by our results showing that removal of 
S3-containing isoforms can cause mitochondrial fragmentation under basal growth conditions.  
 
MATERIALS AND METHODS 
 
Antibodies 
The following antibodies were used: anti-Actin (Mab1501R, Millipore), anti-HSP60 (SC-1054, 
Santa Cruz Biotech), anti-FLAG (F-1804, Sigma), anti-OPA1 (612606, BD Biosciences), anti-TOMM20 
(FL-145, Santa Cruz Biotech), anti-TUBULIN (T6199, Sigma), anti-OMA1 (sc-515788, Sigma), and 
anti-YME1L (11510, Protein Tech Group). 
 
Western Blot 
Homemade 8% SDS-PAGE gel was used prior to switching to high resolution gel system.  
High resolution gel system: The Bio-Rad Mini-PROTEAN precast gel system was used for Western 
blotting. 10ug of each cell lysate sample was loaded onto 7.5% Mini-PROTEAN TGX precast gels, run at 
150 V at 4°C for 2 hours to resolve OPA1 bands, then transferred onto nitrocellulose membranes using 
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Semi-dry Transfer Cell (Bio-Rad), immunoblotted with primary antibodies followed by horseradish 
peroxidase-conjugated secondary antibodies. Densitometry of Western blots was done using ImageJ. 
 
Plasmid construction and retroviral transduction 
The eight isoforms of human OPA1 cDNA were described previously (Song et al., 2007). FLAG-
tagged OPA1 isoforms were constructed by inserting a 3XFLAG sequence (amino acid sequence: 
DYKDHDGDYKDHDIDYKDDDDK) into the 3’ end of the OPA1 gene at the MfeI/NotI site. OPA1 
sequences are highly similar between mouse and human (Fig. S4B). 
To generate the OPA1 bicistronic expression system, isoform 1 was cloned into pMSCV-IRES-
YFP II (Addgene, #52108) at BamHI/ApaI sites. Isoform 5 was then cloned into NcoI/HpaI sites, 
replacing YFP.  
To generate mutants of OPA1 isoform 5, primers containing deletion mutations were used to 
amplify 5’ and 3’ OPA1 fragments, which were then fused together by PCR. The amplified DNA 
fragments were subcloned back into the pMSCV-Opa1 isoform 5 vector and expressed via retroviral 
infection.  
To disrupt Opa1 exon 5b, CRISPR-Cas9 sgRNA was analyzed by the online gRNA design 
platform at crispr.mit.edu. The gRNA sequence with the highest score was selected and cloned into the 
pSpCas9n(BB)-2A-Puro plasmid. Transfection and selection were done as previously reported (Ran et al., 
2013). The guide RNA was generated by the following oligonucleotides:  
Forward:        CACCGGGGCATAGCTCGTGCTATAC 
Reverse:   AAACGTATAGCACGAGCTATGCCCC 
shRNAs were cloned into the BglII/EcoRI sites of the retroviral vector pRetroX-H1, which contains the 
H1 promoter. The shRNA target sequences were: 
Opa1 exon4b: GGTTAGTGAAGTCCTAGAAGT 
Oma1: GCAGTCTACCAGGATAAATCG 
Yme1l: GCAAATGCTCCTTGTGTTATA 
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Non-targeting: GACTAGAAGGCACAGAGGG 
All constructs were authenticated by DNA sequencing. 
 
Mouse breeding 
Cas9 mRNA and sgRNA targeting Opa1 exon 5b were injected into fertilized oocytes at the one 
cell stage by the Transgenic/Knockout Rodent Core Facility at USC. The genotypes of the animals were 
analyzed by PCR and DNA sequencing, and animals with frameshift mutations were selected. Two 
homozygous mutant mouse lines—one with a 13-nucleotide deletion and the other with a 44-nt 
deletion—were found to lack OPA1 transcripts containing exon 5b. These ∆exon 5b mice were 
subsequently crossed to Oma1-null mice to generate ∆exon 5b/Oma1-null animals. Mouse experiments 
were conducted under protocols approved by the Caltech Institutional Animal Care and Use Committee.  
 
Cell lines and cell culture 
MEFs (mouse embryonic fibroblasts) were maintained in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin at 37 °C and 
5% CO2. OXPHOS-inducing medium and glycolytic medium were described previously (Mishra et al., 
2014).  
The Opa1-null, Oma1-null, Yme1l-null and Oma1/Yme1l-null MEFs were described previously 
(Song et al., 2007; Anand et al., 2014). To generate ∆exon 5b MEFs, WT MEFs were transiently 
transfected with the CRISPR-Cas9 plasmid. 24 hours later the transfected MEFs were selected with 1 µM 
puromycin for 24 hours, and cells were cloned by limiting dilution in 96-well plates. After expansion, the 
clones were lysed with RIPA buffer (ThermoFisher Scientific) and analyzed by Western blotting against 
OPA1. Clones with the expected OPA1 band pattern were expanded, and their genotypes were confirmed 
by DNA sequencing.  
To generate ∆exon 5b/Oma1-null fibroblasts, cells were isolated from ∆exon 5b/Oma1 mouse 
tails at postnatal day 21 and grown in DMEM supplemented with 10% fetal bovine serum (FBS), 
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essential amino acids, and penicillin/streptomycin at 37 °C and 5% CO2
 
. The fibroblasts were 
immortalized by expression of SV40 large T antigen. The genotype of the cells was confirmed by PCR 
and immunoblotting.  
Cell respiration measurement 
Oxygen consumption rate was measured in a Seahorse Biosciences Extracellular Flux Analyzer 
(model XF96), as described previously (Mishra et al., 2014). 
 
Imaging and quantification 
All images were acquired with a Zeiss LSM 710 confocal microscope with a Plan-Apochromat 
63X/1.4 oil objective. Alexa 488 and Alexa 546 conjugated dyes were excited by the 488 nm laser and the 
561 nm laser respectively. Mitochondria were visualized and imaged by immunostaining with Tom20 
antibody. 
To determine mitochondrial fusion activity, cells were visually scored under a fluorescent microscope 
(Axiovert 200M; Carl Zeiss MicroImaging, Inc.) into four morphological classifications. Scoring was 
done manually, blinded. “Fragmented” refers to cells that contain spherical mitochondrial fragments with 
no more than two short tubules found. “Short tubular” refers to cells with mixture of fragmented and short 
tubular mitochondria. “Long tubular” refers to cells in which mitochondria were elongated, but not highly 
interconnected into a mitochondrial mesh. “Interconnected” refers to cells in which mitochondria formed 
a highly interconnected network of mitochondrial filaments, with few isolated mitochondria. All data are 
presented as mean ± s.d (standard deviation) unless otherwise noted. Quantitative data were analyzed by 
Student’s t-test for the comparison between two groups (two tailed, unpaired). 
 
PA-GFP fusion assay 
Cells expressing matrix DsRed and photoactivatable GFP (PA-GFP) targeted to either the OM or 
matrix were plated on glass coverslips and imaged live at 37°C on an LSM 710 confocal microscope 
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(Carl Zeiss, Inc.). Measurements were initiated 1-2 hours after medium change. PA-GFP was 
photoactivated in a region of interest (5 μm × 5 μm) by illumination with a 405 nm laser. The activated 
fluorescent signal was then collected (for the entire cell) every 3 min for the next 30 min using a spectral 
detector, followed by spectral unmixing based on the individual PA-GFP and DsRed spectra. Fusion 
events result in the dilution of the activated signal. The average pixel intensity (for the entire cell) over 
time is a measurement of fusion rates (Karbowski et al., 2014). Images were analyzed in MatLab 
(Mathworks, Inc.). P values were calculated using a Student’s t test on the slopes of intensity versus time 
for individual measurements (>20 per condition). 
 
Mass Spectrometry 
At 48 hours after transient transfection of FLAG-tagged isoform 5 in 293T cells, cell lysates were 
harvested and immune-precipitated against FLAG. Concentrated samples were run on SDS-PAGE, and 
colloidal Coomassie blue stain (Invitrogen) was used to identify the bands. The desired bands were 
excised, finely diced, and transferred to a microcentrifuge tube. The gel pieces were reduced, alkylated, 
and digested by trypsin overnight at 37° C. Digested peptides were extracted from the gel, lyophilized, 
and desalted by C18 ZipTips (EMD Millipore). The peptides were separated with a 60 min gradient at a 
flow rate of 220 nL/min using a nanoflow LC system, EASY-nLC 1000, (Thermo Fisher Scientific). The 
separated peptides were ionized by a Nanospray Flex ion source and subjected to MS/MS analysis using a 
Fusion Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose). LC-MS/MS Data Analysis: The 
Thermo raw data file was converted to mzML file using MSconvert. The mzML file was searched using 
MS-GF+ against the Opa1 sequence. Default options were used except precursor mass tolerance was set 
to 7 ppm, instrument was specified to “Orbitrap/FTICR/Lumos” (1), and enzyme was “Unspecific 
cleavage” (0). Results were further refined by filtering out all peptide-spectrum matches with an E-value 
greater than 0.001. 
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Figure 1: OMA1 and YME1L differentially regulate OPA1 fusion activity. 
(A) Schematic of mouse OPA1 protein isoforms, showing the origin of protein bands a-e. MEFs express 
isoforms 1, 5, 7, and 8. Isoforms 1 and 7 produce long forms that constitute bands a-b and short forms 
that constitute bands c-e. Isoforms 5  and 8 produce exclusively short forms expected to co-migrate with 
bands c-e, but for simplicity, bands c-e are labeled according to their origin from isoforms 1 and 7. The 
MPP (Mitochondrial Processing Peptidase), S1 (by OMA1), and S2 (by YME1L) cleavage sites are 
indicated with arrows. Orange line and arrows show that band c and d are derived from long isoform 7/a, 
pink line and arrow show that band e is derived from the long isoform 1/b. (B) Western blot analysis of 
OPA1 bands in Oma1 and Yme1l mutant MEFs. Five OPA1 bands (a-e) are apparent in wildtype MEFs. 
Oma1-null MEFs lack c and e; Yme1l-null MEFs lack d; and Oma1/Yme1l-null MEFs lack all the short 
forms, c-e. Tubulin was used as loading control. (C) Representative images of mitochondrial morphology 
(mito-DsRed) in WT and protease-null MEFs in different media. GLY: high glucose medium; OXI: 
OXPHOS-inducing medium; CHX: high glucose medium with 10 µM cycloheximide. Insets show 
magnified view. Scale bar, 5 µm. (D) Quantification of mitochondrial morphology of cells in (C). In each 
experiment, 100 cells were scored. Error bars show standard deviation from three independent 
experiments. (E) Comparison of mitochondrial fusion rates in vivo in different media between WT and 
Oma1/Yme1l-null MEFs. Fusion activity was measured by the intensity reduction of PA-GFP as a 
function of time. Error bars represent standard deviations from at least 6 independent measurements. 
 
Figure 2: The S2 site encoded by Opa1 exon 5b is necessary for OXPHOS-induced fusion in vivo. 
(A) Schematic of exon 5b, showing locations of S2 and CRISPR-Cas9 gRNA target. Deletions present in 
clones 1 and 2 are indicated. (B) Schematic of OPA1 isoform composition after exon 5b-containing 
isoforms are eliminated; Red X’s indicate isoforms expected to be missing in mutant cells. (C) Western 
blot analysis of ∆exon 5b MEF clones. Clones 1 and 2 are positive clones that show the expected 
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disappearance of bands a, c and d. The last lane is a negative clone. Tubulin was used as loading control. 
(D) Quantification of mitochondrial morphology in WT and two ∆exon 5b clones in the indicated media. 
100 cells were counted for each experiment. Error bars indicate standard deviation from three 
independent experiments. 
 
Figure 3: Detection of a new OPA1 cleavage in WT and ∆exon 5b cells 
(A) Higher resolution Western analysis of WT, ∆exon 5b and ∆exon 5b/Oma1-null MEFs. Note the 
additional band located under d in WT MEFs. This band (referred to as d’) is more clearly seen in ∆exon 
5b and ∆exon 5b/Oma1-null clones. HSP60 was used as loading control. (B) Dependence of band d’ on 
Yme1l. Cells expressing the indicated shRNA were analyzed by Western blotting. The two sets of panels 
were run on the same gel. HSP60 was used as loading control. (C) PCR analysis of Opa1 transcripts in 
∆exon 5b cells. The forward primer is located in exon 3, and the reverse primer is located in exon 7 (Fig. 
S3C). Bands corresponding to isoforms 1 and 5 were confirmed by sequencing. (D) Schematic of full-
length OPA1 isoforms 1 and 5. (E) Western blot analysis of the short form produced by isoform 5. HSP60 
was used as loading control. (F) Dependence of isoform 5 band d’ on YME1L. FLAG-tagged human 
OPA1 (isoform 1 or 5) was expressed in cells of the indicated genotype and analyzed by Western blotting 
against FLAG. HSP60 was used as loading control.  
 
Figure 4: Identification of the YME1L-dependent OPA1 S3 cleavage site within exon 4b 
(A) Dependence of band d’ on exon 4b. ShRNA against Opa1 exon 4b was expressed in cells of the 
indicated genotype. Asterisks highlight band d’. HSP60 was used as loading control. (B) Schematic of 
Opa1 exon 4b mutants. On top, the polypeptide sequence encoded by exon 4b (red) and exon 5 (blue) is 
shown. The red arrow indicates the known S1 cleavage site in exon 5; the green arrows indicate the new 
S3 sites found in this study. The isoform 5 mutants are listed, along with amino acids deleted within exon 
4b. (C) Effect of exon 4b mutants on OPA1 processing. FLAG-tagged exon 4b mutants of human isoform 
5 were expressed in Opa1-null MEF cells and analyzed by Western blot. FLAG-tagged WT isoforms 1 
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and 5 were used as controls. HSP60 was used as loading control. (D) Effect of OMA1 and YME1L on 
OPA1 processing in isoform 5 mutants. WT human Iso 5 and its mutant 2, 6 and 7 were expressed in 
Oma1- and Yme1l- null MEFs, FLAG-tagged OPA1 band patterns were analyzed by Western blot. HSP60 
was used as loading control. (E) Identification of likely S3 cleavage sites within exon 4b by tandem mass 
spectrometry of band d’. Band d’ was produced by expression of FLAG-tagged Opa1 isoform 5 in 293T 
cells, purified by anti-FLAG immunoprecipitation, resolved by SDS-PAGE, digested by trypsin, and 
subjected to tandem mass spectrometry. Left: Schematic indicates the three ragged N-terminal peptides 
identified, colored according to their relative intensity. Right: Plot of the intensity of the three peptides. 
(F) Effect of penta-leucine mutants on generation of band d’. As indicated, alanines were used to replace 
1, 2 or 3 leucines within the C-terminal penta-leucine stretch encoded by exon 4b. FLAG-tagged mutants 
of isoform 5 were expressed in Opa1-null cells and analyzed by Western blot. HSP60 was used as loading 
control. (G) Schematic of the OPA1 isoform profile in ∆exon 5b MEFs. Green arrow represents the new 
S3 site identified.  
 
Figure 5: The S3-cleaved short form of isoform 5 regulates mitochondrial morphology 
(A) Elongation of mitochondria by isoform 5 mutants. Isoform 5 mutants were expressed in Opa1-null 
cells, and mitochondrial morphologies were quantified. Error bars indicate standard deviation from six 
independent experiments. (B) Depletion of band d’ by shRNA against exon 4b and re-expression of d’ by 
isoform 5. Ectopic expression of isoform 5 is sufficient to overcome the shRNA effect and produce d’. 
OPA1 isoforms were analyzed by Western blotting against OPA1. HSP 60 was used as loading control. 
(C) Effect of exon 4b shRNA on mitochondrial morphology. Error bars indicate standard deviation from 
three independent experiments. (D) Analysis of bicistronic OPA1 expression. Opa1-null cells expressing 
isoform 1 or isoform 1 plus isoform 5 were analyzed by Western blotting against OPA1. ∆exon 5b cells 
are shown for comparison. HSP60 was used as loading control.  (E) Effect of band d’ on mitochondrial 
morphology. Quantification of mitochondrial morphology of Opa1-null MEFs expressing isoform 1 with 
YFP or isoform 1 with isoform 5. Error bars indicate standard deviation from three independent 
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experiments. P values for the fragmented, short tubular, long tubular and interconnected were 4.8x10-4, 
0.04, 0.001, 9.9x10-7 respectively. P-values were calculated by student’s t-test. (F) Model showing the 
OPA1 isoforms under normal and S3 disrupted conditions. When S3 is disrupted (bottom panel, box), 
cleavages at S1 and cryptic sites are activated, preserving production of s-OPA1. OM: outer membrane, 
IM: inner membrane. 





